Polaris Group (6550.TW)

TWD 37.6

(1.9%)

Total Assets Summary of Polaris Group

  • Polaris Group's latest annual total assets in 2023 was 9.09 Billion TWD , down -1.32% from previous year.
  • Polaris Group's latest quarterly total assets in 2024 Q2 was 9.08 Billion TWD , up 2.64% from previous quarter.
  • Polaris Group reported annual total assets of 9.21 Billion TWD in 2022, up 17.86% from previous year.
  • Polaris Group reported annual total assets of 7.82 Billion TWD in 2021, up 132.64% from previous year.
  • Polaris Group reported quarterly total assets of 8.85 Billion TWD for 2024 Q1, down -2.7% from previous quarter.
  • Polaris Group reported quarterly total assets of 9.09 Billion TWD for 2023 Q4, down -3.17% from previous quarter.

Annual Total Assets Chart of Polaris Group (2023 - 2016)

Historical Annual Total Assets of Polaris Group (2023 - 2016)

Year Total Assets Total Assets Growth
2023 9.09 Billion TWD -1.32%
2022 9.21 Billion TWD 17.86%
2021 7.82 Billion TWD 132.64%
2020 3.36 Billion TWD -18.11%
2019 4.1 Billion TWD 107.83%
2018 1.97 Billion TWD -11.08%
2017 2.22 Billion TWD 12.77%
2016 1.97 Billion TWD 0.0%

Peer Total Assets Comparison of Polaris Group

Name Total Assets Total Assets Difference
Apex Biotechnology Corp. 2.29 Billion TWD -296.079%
Sinphar Pharmaceutical Co.,Ltd. 6.25 Billion TWD -45.542%
Panion & Bf Biotech Inc. 3.23 Billion TWD -181.219%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 5.17 Billion TWD -75.92%
GenMont Biotech Incorporation 1.65 Billion TWD -450.33%
Abnova (Taiwan) Corporation 1.35 Billion TWD -571.068%
Adimmune Corporation 9.48 Billion TWD 4.075%
Tanvex BioPharma, Inc. 2.76 Billion TWD -229.23%
Energenesis Biomedical CO.,LTD. 828.57 Million TWD -998.031%
UnicoCell Biomed Co., Ltd. 685.92 Million TWD -1226.37%
PELL Bio-Med Technology Co. Ltd. 1.41 Billion TWD -541.534%